respiratory diseases
respiratory diseases
Revolutionary Needle-Free mRNA Vaccines for Flu!
BIOT
🌟 Ethris and Lonza team up for room-temperature stable, spray-dried mRNA vaccines targeting respiratory diseases. 💉 Needle-free, efficient distribution! 🌍🚀
Game-Changing Respiratory Breakthrough: GSK’s $14bn Aiolos Bio Acquisition!
BIOT
📢 GSK breathes new life into its respiratory pipeline with $1.4bn Aiolos Bio acquisition, reinforcing commitment to patients worldwide. 😷💊🌍
